Herceptin, Enbrel Face First Biosimilar Rivals In Japan But Outlook Uncertain

 
• By Ian Haydock
  
Tokyo
NEW BIOSIMILAR LAUNCHES IN JAPAN • Source: Shutterstock

More from Japan

More from Focus On Asia